SEC Form 4 · accession 0001493152-26-035273
Biofrontera Inc. · BFRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hermann Luebbert
Officer — CEO & Chairman · Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 29, 2026 · 5:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001858685
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 28, 2026 | M | 62,500 | — | A | 352,711 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F1,F2 | — | Jul 28, 2026 | M | 62,500 | D | — | — | Common Stock | 62,500 | 62,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis.
- F2On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
- F3Restricted stock units with different terms are not included.